Letter: Entecavir versus tenofovir on serum lipoprotein levels of hepatitis B virus-related hepatocellular carcinoma after curative hepatectomy-Author's reply

被引：0
|
作者：
Ogawa, Eiichi [1 ,2 ]
机构：
[1] Kyushu Univ Hosp, Dept Gen Internal Med, Fukuoka, Japan
[2] Kyushu Univ Hosp, Dept Gen Internal Med, 3-1-1 Maidashi,Higashi Ku, Fukuoka 8128582, Japan
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2023年 / 58卷 / 08期
关键词：
D O I：
10.1111/apt.17693
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
LINKED CONTENT This article is linked to Ogawa et al papers. To view these articles, visit and
引用
收藏
页码：845 / 846
页数：2
相关论文
共 50 条
  • [21] Tenofovir versus Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma After FOLFOX-Hepatic Arterial Infusion Chemotherapy
    Zheng, Zhikai
    Wang, Jiongliang
    Wu, Tianqing
    He, Minrui
    Wang, Juncheng
    Pan, Yangxun
    Chen, Jinbin
    Hu, Dandan
    Xu, Li
    Zhang, Yaojun
    Chen, Minshan
    Zhou, Zhongguo
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 : 2117 - 2132
  • [22] Tenofovir vs Entecavir on the Prognosis of Patients With Hepatitis B Virus-Related Hepatocellular Carcinoma After Liver Resection: The Role of HBsAg Levels
    Qiu, Zhancheng
    Xu, Yueqing
    Qi, Weili
    Shen, Junyi
    Wen, Tianfu
    Li, Chuan
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2025, 16 (03)
  • [23] Lamivudine versus Entecavir for Newly Diagnosed Hepatitis B Virus-Related Hepatocellular Carcinoma
    Kim, Jung Hee
    Sinn, Dong Hyun
    Kim, Kyunga
    Kim, Hyeseung
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    GUT AND LIVER, 2016, 10 (06) : 939 - 947
  • [24] Risk of hepatocellular carcinoma with tenofovir versus entecavir in chronic hepatitis B Reply
    Tseng, Cheng-Hao
    Hsu, Yao-Chun
    Nguyen, Mindie H.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (02): : 87 - 88
  • [25] Entecavir and Tenofovir More Effectively Reduce the Recurrence of Hepatitis B Virus-related Hepatocellular Carcinoma after Curative Treatment than Low-potent Antivirals
    Ahn, Hongkeun
    Lee, Jeong-Hoon
    Chang, Young
    Nam, Joon Yeul
    Cho, Hyeki
    Cho, Young Youn
    Lee, Minjong
    Yoo, Jeong-Ju
    Cho, Yuri
    Lee, Donghyeon
    Cho, Eun Ju
    Yu, Su Jong
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Lee, June Sung
    HEPATOLOGY, 2015, 62 : 1191A - 1192A
  • [26] Antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after radical hepatectomy
    Yang Ke
    Liang Ma
    Xue-Mei You
    Sheng-Xin Huang
    Yong-Rong Liang
    Bang-De Xiang
    Le-Qun Li
    Cancer Biology & Medicine, 2013, (03) : 158 - 164
  • [27] Antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after radical hepatectomy
    Yang Ke
    Liang Ma
    Xue-Mei You
    Sheng-Xin Huang
    Yong-Rong Liang
    Bang-De Xiang
    Le-Qun Li
    Cancer Biology & Medicine, 2013, 10 (03) : 158 - 164
  • [28] Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a reconstructed individual patient data meta-analysis
    Peng, Jian-Xin
    Wang, Ling-Zhi
    Wang, Qiu-Ting
    Li, Hui-Long
    Lin, Li-Jun
    He, Jun-Ming
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [29] Nomograms in Hepatectomy Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma
    Jong Man Kim
    Choon Hyuck David Kwon
    Jae-Won Joh
    Heejin Yoo
    Kyunga Kim
    Dong Hyun Sinn
    Gyu-Seong Choi
    Joon Hyeok Lee
    Journal of Gastrointestinal Surgery, 2019, 23 : 1559 - 1567
  • [30] Letter: tenofovir versus entecavir for hepatocellular carcinoma prevention in chronic hepatitis B-related compensated cirrhosis-authors' reply
    Chiu, Sherry Yueh-Hsia
    Chang, Kuo-Chin
    Hu, Tsung-Hui
    Chien, Rong-Nan
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (09) : 1042 - 1043
12345